Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00800176 · ClinicalTrials.gov registry record · Phase 2
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A Phase 2 study, sponsored by Hoffmann-La Roche.
- Completed
- Registry status
- Phase 2
- Development phase
- 394
- Enrollment target
NCT00800176 is a Phase 2 study that has completed, run by Hoffmann-La Roche. The registered enrollment target is 394 participants.
The verdict
NCT00800176, a Phase 2 study, has completed, sponsored by Hoffmann-La Roche.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 394 participants
- Enrollment target
Study Summary
This 6 arm study will evaluate the efficacy, safety and pharmacokinetics of 5 doses of RO4998452 compared to placebo in patients with type 2 diabetes mellitus. Patients will be randomized to one of 6 groups to receive RO4998452 at doses of 2.5mg, 5mg, 10mg, 20mg or 40mg po daily, or placebo daily. Patients pre-treated with stable metformin will continue to take their usual dose of metformin throughout the study.The anticipated time on study treatment is \<=3 months
Interventions
- DRUG Placebo
- DRUG RO4998452
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 394 participants |
| Start Date | 2009-01-22 |
| Est. Completion | 2009-10-28 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00800176
The ClinicalTrials.gov registry entry for NCT00800176 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 394 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hoffmann-La Roche, which has 909 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00800176 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00800176 about?
NCT00800176 is a clinical study titled "A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus". This 6 arm study will evaluate the efficacy, safety and pharmacokinetics of 5 doses of RO4998452 compared to placebo in patients with type 2 diabetes mellitus. Patients will be randomized to one of 6 groups to receive RO4998452 at doses of 2.5mg, 5mg, 10mg, 20mg or 40mg po daily, or placebo daily. P...
What is the current status of trial NCT00800176?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 394 participants. The study started on 2009-01-22. Estimated completion is 2009-10-28.
What interventions are being tested in trial NCT00800176?
The interventions under investigation include: Placebo (DRUG), RO4998452 (DRUG).
Who is sponsoring clinical trial NCT00800176?
This trial is sponsored by Hoffmann-La Roche, which has 909 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.